SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Idenix Pharmaceuticals, Inc. Reports Clinical Data for HCV Drug Candidates - IDX719 and IDX184 - at the American Association for Study of Liver Diseases Annual Meeting